Publication | Closed Access

Study of double-targeting nanoparticles loaded with MCL-1 siRNA and dexamethasone for adjuvant-induced arthritis therapy

NanomedicineRheumatologyAdjuvant-induced Arthritis TherapyDouble-targeting NanoparticlesMedicineTherapeutic NanomaterialsImmunologyOsteoarthritisInflammatory Rheumatic DiseaseNano-drug DeliveryPharmacologyRheumatoid ArthritisMcl-1 Sirna